This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Rheumatology
Rheumatology
Watchdog approves arthritis drug
Profits up at Merck target Schering
IDEA reports results from a prospective 3 years phase III study of Diractin (ketoprofen in Transfersome gel)
NICE guidance for arthritis regime
Osteoporosis drug rethink ordered
Arthritis drug “can cause shingles”
Arthritis sufferers offered hope
Duloxetine significantly reduces osteoarthritis knee pain
RoACTEMRA approved in Europe to treat RA
NICE denies drugs ban is illegal
UCB announce news of FDA’s complete response letter
Exemestane “reduces bone density”
« Previous
1
…
20
21
22
23
24
…
31
Next »
Most read
1
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: